More topics

Limited coverage criteria - Angiotensin receptor blockers – irbesartan

Last updated on March 4, 2025

Generic name

 irbesartan, including in combination with hydrochlorothiazide

Strength & form

 75 mg, 150 mg, 300 mg, 150 mg/12.5 mg, 300 mg/12.5 mg, 300 mg/25 mg tablet

Special Authority Criteria

Approval period
  1. Person identified as experiencing intractable cough or angioedema on an Angiotensin Converting Enzyme Inhibitor (ACE-I)

    AND
     
  2. Failure on optimal doses of, or intolerance to, ALL reference drugs: candesartan, losartan, telmisartan AND valsartan

Indefinite

Practitioner exemptions

  • No practitioner exemptions

Special notes

  • Individuals requiring a diuretic combination product must satisfy the same criteria

Special Authority request form